Showing 15,441 - 15,460 results of 32,304 for search '(( 50 ((((a decrease) OR (we decrease))) OR (mean decrease)) ) OR ( e point decrease ))', query time: 0.78s Refine Results
  1. 15441
  2. 15442

    Table_1_Liver Transcriptomic Analysis of the Effects of Dietary Fish Oil Revealed a Regulated Expression Pattern of Genes in Adult Female Spotted Scat (Scatophagus argus).DOCX by Tuo Wang (1412575)

    Published 2022
    “…The expression levels of Foxo1a and Lep, which are involved in the lipid metabolism, decreased significantly in the FO group, which may be related to the lower level of HSI in the FO group. …”
  3. 15443

    Table 1_Association between abdominal obesity and cognitive decline among Chinese middle-aged and older adults: a 10-year follow-up from CHARLS.docx by Qiong Wu (84327)

    Published 2025
    “…After controlling for confounders, participants with abdominal obesity were less likely to experience rapid decline (OR: 0.67, 95%CI: 0.51–0.8) and slow decline (OR: 0.81, 95%CI: 0.69–0.95) of cognitive function, compared to those with normal WC. RCS analysis showed a decreased risk of cognitive decline with increasing WC. …”
  4. 15444
  5. 15445
  6. 15446

    Image_1_Changes in gut microbiota composition after 12 weeks of a home-based lifestyle intervention in breast cancer survivors during the COVID-19 lockdown.pdf by Sabrina Donati Zeppa (16917315)

    Published 2023
    “…</p>Results<p>Beneficial effects of the LI were observed on MD adherence, and cardiometabolic parameters (pre vs post). A robust reduction of Proteobacteria was observed after LI, which is able to reshape the gut microbiota by modulating microorganisms capable of decreasing inflammation and others involved in improving the lipid and glycemic assets of the host. …”
  7. 15447

    Table_1_Liver Transcriptomic Analysis of the Effects of Dietary Fish Oil Revealed a Regulated Expression Pattern of Genes in Adult Female Spotted Scat (Scatophagus argus).DOCX by Tuo Wang (1412575)

    Published 2021
    “…The expression levels of Foxo1a and Lep, which are involved in the lipid metabolism, decreased significantly in the FO group, which may be related to the lower level of HSI in the FO group. …”
  8. 15448

    Liver disease burden and required treatment expenditures for hepatitis C virus (HCV) infection in Thailand: Implications for HCV elimination in the new therapeutic era, a populatio... by Rujipat Wasitthankasem (732723)

    Published 2018
    “…In areas of both high (12%) and average (2%) HCV viremic prevalence, over half of the patients (52.2% to 62.5%) had advanced liver fibrosis (F3 and F4). A striking percentage of patients with F4 (38.9%) were found in the high-prevalence area, while comparable proportions of advanced liver fibrosis presented in the two areas and disease burden peaked at 50–59 years. …”
  9. 15449

    Data_Sheet_1_Long-term phenobarbital treatment is effective in working-age patients with epilepsy in rural Northeast China: a 10-year follow-up study.docx by Rongxin Li (3552779)

    Published 2024
    “…During the first year of treatment, 75.2% of patients experienced a50% reduction in seizure frequency compared with baseline (considered as treatment effectiveness); 53.7% of patients were seizure-free. …”
  10. 15450

    Data_Sheet_1_A Potent Histone Deacetylase Inhibitor MPT0E028 Mitigates Emphysema Severity via Components of the Hippo Signaling Pathway in an Emphysematous Mouse Model.docx by Lu-Yang Yeh (12559033)

    Published 2022
    “…</p>Results<p>50 mg/kg BW of the MPT0E028 significantly decreased the tidal volume in emphysematous mice (p < 0.05). …”
  11. 15451
  12. 15452

    HrrF expression is iron-responsive and Fur-dependent. by Estevan A. Santana (621708)

    Published 2014
    “…<p><b>A.</b> Total RNA was purified from strains 86-028NP<i>rpsL</i>, 86-028NP<i>rpsL</i>Δ<i>fur</i>, 86-028NP<i>rpsL</i>Δ<i>fur</i>Δ<i>hrrF<sub>L</sub>,</i> and 86-028NP<i>rpsL</i>Δ<i>fur</i>Δ<i>hfq</i> grown in DIS to mid-logarithmic phase at 37°C with shaking at 50rpm. …”
  13. 15453

    Table_1_The beneficial effect of sulforaphane on platelet responsiveness during caloric load: a single-intake, double-blind, placebo-controlled, crossover trial in healthy particip... by Hidde P. van Steenwijk (16499940)

    Published 2023
    “…Participants carrying the polymorphic variant NAD(P)H dehydrogenase quinone 1 (NQO1*2) showed decreased excretion of sulforaphane (p = 0.035).</p>Conclusion<p>Sulforaphane was shown to be effective in targeting platelet responsiveness after a single intake. …”
  14. 15454
  15. 15455

    Sour taste initiates GABAergic and serotonergic inhibition in taste buds. by Yijen A. Huang (334066)

    Published 2013
    “…<b>B,</b> In another experiment, ATP secretion stimulated by sweet/bitter tastants (as in A) was strikingly diminished when a sour tastant (HAc, acetic acid 10 mM, pH 5.0) was added to the stimulus mix (↓, taste/HAc). …”
  16. 15456

    In Patients with Established RA, Positive Effects of a Randomised Three Month WBV Therapy Intervention on Functional Ability, Bone Mineral Density and Fatigue Are Sustained for up... by Alessandra Prioreschi (2609719)

    Published 2016
    “…Hip BMD was significantly reduced in the CON group (0.97(0.05) to 0.84(0.05) g.cm<sup>-2</sup>, p = 0.01), while no decreases were seen in the WBV group (1.01(0.05) to 0.94(0.05) g.cm<sup>-2</sup>, p = 0.50). …”
  17. 15457

    Image_1_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.tif by Mengting Chen (1419172)

    Published 2023
    “…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”
  18. 15458

    Image_2_JK5G postbiotics attenuate immune-related adverse events in NSCLC patients by regulating gut microbiota: a randomized controlled trial in China.tif by Mengting Chen (1419172)

    Published 2023
    “…Moreover, the JK5G group had a lower incidence of anemia (63.33% vs. 13.33%, p < 0.001), decreased lymphocyte count (20.00% vs. 0%, p = 0.010), decreased appetite (53.33% vs. 16.67%, p = 0.003), nausea (33.33% vs. 6.67%, p = 0.010), and asthenia (30.00% vs. 6.67%, p = 0.017) than the control group. …”
  19. 15459

    Supplementary Material for: Gonadotropin-Releasing Hormone Agonists During Gonadal Chemotherapy for the Effect on Pregnancy Outcome and Ovarian Function in Premenopausal Patients W... by Yuan Y. (3237453)

    Published 2023
    “…For secondary endpoints, the GnRHa group improved menstrual recovery rates (RR=1.20; 95% CI: 1.11-1.30), and decreased the rate of amenorrhea 1-2 years after chemotherapy (RR=0.50; 95% CI: 0.40-0.63). …”
  20. 15460